Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population-Reference-Cited by-同舟云学术

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

Published:2012-08-06 Issue:1 Volume:12 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Rusconi Stefano,Giacomet Vania,Mameli Chiara,Viganò Alessandra,Viganò Ottavia,Adorni Fulvio,Galli Massimo,Zuccotti Gian Vincenzo

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-12-179/fulltext.html

Reference20 articles.

1. Alella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998, 338: 853-60. 10.1056/NEJM199803263381301.

2. Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, Van Dyke RB: Pediatric AIDS Clinical Trials Group219/219C Team: Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr. 2010, 53: 86-94. 10.1097/QAI.0b013e3181b9869f.

3. de Martino M, Tovo PA, Balducci M, Galli L, Gabiano C, Rezza G, Pezzotti P: Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000, 284: 190-97. 10.1001/jama.284.2.190.

4. Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM: HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS. 1999, 13: F35-43. 10.1097/00002030-199904160-00001.

5. Fätkenheuer G, Theisen A, Rockstroh J, Grabow T, Wicke C, Becker K, Wieland U, Pfister H, Reiser M, Hegener P, Franzen C, Schwenk A, Salzberger B: Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS. 1997, 11: F113-6. 10.1097/00002030-199714000-00001.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review;Frontiers in Pediatrics;2022-05-23

2. First time genotyping of Cryptosporidium spp. isolates from diarrheic stools of Algerian HIV-Infected subjects supports predominant zoonotic transmission routes;2020-04-17

3. The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa;International Journal of Pediatrics;2019-03-03

4. Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS;Reviews in Endocrine and Metabolic Disorders;2013-05-23